These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23052222)

  • 1. Dose-dependent short-term effects of single high doses of oral vitamin D(3) on bone turnover markers.
    Rossini M; Adami S; Viapiana O; Fracassi E; Idolazzi L; Povino MR; Gatti D
    Calcif Tissue Int; 2012 Dec; 91(6):365-9. PubMed ID: 23052222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃.
    Rossini M; Gatti D; Viapiana O; Fracassi E; Idolazzi L; Zanoni S; Adami S
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E622-6. PubMed ID: 22298802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related changes of serum bone alkaline phosphatase and cross-linked C-telopeptides of type I collagen and the relationship with bone mineral density in Chinese women.
    Shan PF; Wu XP; Zhang H; Luo XH; Cao XZ; Xie H; Liu SP; Pi YZ; Fang TY; Liu H; Chen ZH; Zhong N; Liao EY
    Clin Chim Acta; 2006 Apr; 366(1-2):233-8. PubMed ID: 16330011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High phosphorus intakes acutely and negatively affect Ca and bone metabolism in a dose-dependent manner in healthy young females.
    Kemi VE; Kärkkäinen MU; Lamberg-Allardt CJ
    Br J Nutr; 2006 Sep; 96(3):545-52. PubMed ID: 16925861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.
    Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Ballaouri I; Efstathiadou Z; Kita M; Avramidis A
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):522-6. PubMed ID: 18625000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of raloxifene on markers of bone turnover in older women living in long-term care facilities.
    Hansdóttir H; Franzson L; Prestwood K; Sigurdsson G
    J Am Geriatr Soc; 2004 May; 52(5):779-83. PubMed ID: 15086661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.
    Jean G; Souberbielle JC; Chazot C
    Nephrol Dial Transplant; 2009 Dec; 24(12):3799-805. PubMed ID: 19622574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calcium fortified milk supplementation with or without vitamin K on biochemical markers of bone turnover in premenopausal women.
    Kruger MC; Booth CL; Coad J; Schollum LM; Kuhn-Sherlock B; Shearer MJ
    Nutrition; 2006; 22(11-12):1120-8. PubMed ID: 17030114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J; Roszkowska-Blaim M; Pańczyk-Tomaszewska M
    Przegl Lek; 2007; 64(9):552-8. PubMed ID: 18510075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between the polymorphism of start codon and CDX2 site in vitamin D receptor gene and the effect of calcium supplementation on bone mineral density of postmenopausal women].
    Zhang ZL; He JW; Huang QR; Qin YJ; Hu YQ; Li M; Zhang H; Liu YJ; Hu WW
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):397-401. PubMed ID: 16883525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phylloquinone supplementation on biochemical markers of vitamin K status and bone turnover in postmenopausal women.
    Bügel S; Sørensen AD; Hels O; Kristensen M; Vermeer C; Jakobsen J; Flynn A; Mølgaard C; Cashman KD
    Br J Nutr; 2007 Feb; 97(2):373-80. PubMed ID: 17298708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab.
    Gatti D; Viapiana O; Fracassi E; Idolazzi L; Dartizio C; Povino MR; Adami S; Rossini M
    J Bone Miner Res; 2012 Nov; 27(11):2259-63. PubMed ID: 22692843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases.
    Amir E; Simmons CE; Freedman OC; Dranitsaris G; Cole DE; Vieth R; Ooi WS; Clemons M
    Cancer; 2010 Jan; 116(2):284-91. PubMed ID: 19918922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A weekly 35,000 IU vitamin D supplementation improves bone turnover markers in vitamin D deficient Saudi adolescent females.
    Sulimani RA; Mohammed AG; Alshehri SN; Alfadda AA; Al-Othman A; Khan AA
    Arch Osteoporos; 2017 Sep; 12(1):85. PubMed ID: 28963655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
    Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
    J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ability of biochemical markers of bone turnover to predict a response to increased doses of HRT.
    Rosen HN; Parker RA; Greenspan SL; Iloputaife ID; Bookman L; Chapin D; Perlmutter I; Kessel B; Qvist P; Rosenblatt M
    Calcif Tissue Int; 2004 May; 74(5):415-23. PubMed ID: 14961215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction.
    Brazier M; Kamel S; Maamer M; Agbomson F; Elesper I; Garabedian M; Desmet G; Sebert JL
    J Bone Miner Res; 1995 Nov; 10(11):1753-61. PubMed ID: 8592953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.